MARKET

MCK

MCK

McKesson
NYSE

Real-time Quotes | Nasdaq Last Sale

179.00
-0.91
-0.51%
Closed 19:45 12/01 EST
OPEN
183.06
PREV CLOSE
179.91
HIGH
183.54
LOW
178.82
VOLUME
1.16M
TURNOVER
--
52 WEEK HIGH
187.67
52 WEEK LOW
112.60
MARKET CAP
28.74B
P/E (TTM)
13.77
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
McKesson Corporation -- Moody's rates McKesson Corporation's new senior unsecured bonds at Baa2
Moody's · 1d ago
Moderna to file for emergency approval of COVID-19 vaccine candidate
Moderna is moving closer to having its COVID-19 vaccine candidate available for distribution, as the biotechnology company said Monday it plans to request an...
MarketWatch · 1d ago
Moderna Announces Primary Efficacy Analysis In Phase 3 COVE Study For Its COVID-19 Vaccine Candidate; Vaccine Efficacy Against COVID-19 Was 94.1%, Vaccine Efficacy Against Severe COVID-19 Was 100%
Primary efficacy analysis of the Phase 3 COVE study of mRNA-1273 involving 30,000 participants included 196 cases of COVID-19, of which 30 cases were severe Vaccine efficacy against COVID-19 was 94.1%; vaccinePrimary efficacy analysis of the Phase 3 COVE study of mRNA-1273 involving 30,000 participants included 196 cases of COVID-19, of which 30 cases were severe
Benzinga · 1d ago
Purdue Pharma pleads guilty to criminal opioid crisis charges
Purdue Pharma has formally admitted its role in an opioid epidemic that has contributed to hundreds of thousands of deaths over the past two decades.The OxyContin maker pleaded guilty to
Seekingalpha · 11/25 08:49
McKesson Corporation (NYSE:MCK) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Readers hoping to buy McKesson Corporation (NYSE:MCK) for its dividend will need to make their move shortly, as the...
Simply Wall St. · 11/25 06:36
Texas hospitals prepare to administer Covid vaccine shots in less than three weeks
"I didn't expect to get vaccine so soon, frankly," chief clinical officer of UT Health Dr. Amy Young said. "We'll be ready for it whenever we get it."
CNBC.com · 11/24 19:45
McKesson Could Move Higher So Trade It From the Long Side
MCK is a Covid vaccine distribution play....MCK
TheStreet.com · 11/24 18:35
McCormick looks for some spice with Cholula acquisition
McCormick (MKC) is moving over the bottle of Frank's as it eyes a new hot sauce.The seasonings company is discussing a deal with L Catterton, the private-equity firm that has
Seekingalpha · 11/24 07:32
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MCK. Analyze the recent business situations of McKesson through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 19 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MCK stock price target is 197.50 with a high estimate of 222.00 and a low estimate of 178.00.
EPS
Institutional Holdings
Institutions: 1.25K
Institutional Holdings: 155.25M
% Owned: 96.69%
Shares Outstanding: 160.56M
TypeInstitutionsShares
Increased
267
7.14M
New
139
-1.37M
Decreased
336
10.81M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Drug Retailers
+0.07%
Food & Drug Retailing
+0.27%
Key Executives
Chairman/Independent Director
Edward Mueller
Chief Executive Officer/Director
Brian Tyler
Chief Financial Officer/Executive Vice President
Britt Vitalone
Chief Human Resource Officer/Executive Vice President
Tracy Faber
Executive Vice President/Chief Technology Officer/Chief Information Officer
Nancy Flores
Executive Vice President/Chief Compliance Officer/General Counsel
Lori Schechter
Executive Vice President
Tom Rodgers
Independent Director
Dominic Caruso
Independent Director
N. Anthony Coles
Independent Director
M. Christine Jacobs
Independent Director
Christine Jacobs
Independent Director
N. Coles
Independent Director
Donald Knauss
Independent Director
Marie Knowles
Independent Director
Mary Jacobs
Independent Director
Bradley Lerman
Independent Director
Linda Mantia
Independent Director
Maria Martinez
Independent Director
Susan Salka
Independent Director
Kenneth Washington
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
10/29/2020
Dividend USD 0.42
11/30/2020
07/29/2020
Dividend USD 0.42
08/31/2020
04/29/2020
Dividend USD 0.41
05/29/2020
01/29/2020
Dividend USD 0.41
02/28/2020
10/23/2019
Dividend USD 0.41
11/29/2019
07/31/2019
Dividend USD 0.41
08/30/2019
04/24/2019
Dividend USD 0.39
05/31/2019
01/31/2019
Dividend USD 0.39
02/28/2019
10/24/2018
Dividend USD 0.39
11/30/2018
07/25/2018
Dividend USD 0.39
08/31/2018
04/25/2018
Dividend USD 0.34
05/31/2018
02/01/2018
Dividend USD 0.34
02/28/2018
10/25/2017
Dividend USD 0.34
11/30/2017
07/28/2017
Dividend USD 0.34
08/30/2017
05/25/2017
Dividend USD 0.28
06/01/2017
01/25/2017
Dividend USD 0.28
02/27/2017
10/28/2016
Dividend USD 0.28
11/29/2016
07/27/2016
Dividend USD 0.28
08/30/2016
05/25/2016
Dividend USD 0.28
06/02/2016
01/28/2016
Dividend USD 0.28
02/26/2016
10/30/2015
Dividend USD 0.28
11/27/2015
07/30/2015
Dividend USD 0.28
08/28/2015
05/28/2015
Dividend USD 0.24
06/04/2015
01/29/2015
Dividend USD 0.24
02/26/2015
10/22/2014
Dividend USD 0.24
11/26/2014
07/31/2014
Dividend USD 0.24
08/28/2014
05/28/2014
Dividend USD 0.24
06/05/2014
01/29/2014
Dividend USD 0.24
02/27/2014
10/25/2013
Dividend USD 0.24
11/27/2013
07/26/2013
Dividend USD 0.24
08/29/2013
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About MCK
McKesson Corporation is a healthcare supply chain management solution, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through three segments: United States Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions and Medical-Surgical Solutions. The United States Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare related products and provides pharmaceutical solutions to life sciences companies. European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers. Medical-Surgical Solutions segment distributes medical-surgical supplies and provides logistics and other services to healthcare providers.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of McKesson Corporation stock information, including NYSE:MCK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MCK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MCK stock methods without spending real money on the virtual paper trading platform.